LEIDOS BIOMEDICAL RESEARCH INC - IGF::OT::IGF RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS ? BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)

PIID: HHSN26100019Solicitation ID: N01CO5240180
Signed Date: Sep 15, 2016Effective Date: Sep 19, 2016End Date: Closed on Sep 18, 2021
Award $
$27.5M
Vendor
LEIDOS BIOMEDICAL RESEARCH INC
NAICS
561210
Signed Date
Sep 15, 2016

Key Details

Dollars Obligated
$27.5M
Base & All Options
$27.5M
Awarding Sub-Agency
National Institutes of Health
Parent IDIQ (PIID)
HHSN261201500003I
Product Service Code
M1HA - OPERATION OF GOVERNMENT-OWNED CONTRACTOR-OPERATED (GOCO) R&D FACILITIES
Extent Competed
NOT COMPETED
Place of Performance
FREDERICK, MD

Description

IGF::OT::IGF RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS ? BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)

Context & Analysis

On Sep 15, 2016, Department of Health and Human Services obligated $27,524,748.2 to LEIDOS BIOMEDICAL RESEARCH INC for igf::ot::igf research, development, production and support for clinical trials ? broadly neutralizing monoclonal antibodies (bnmabs). The award is classified under NAICS 561210 — FACILITIES SUPPORT SERVICES. Competition extent: not competed. Performance is located in FREDERICK, MD. This award is one of several similar procurements from Department of Health and Human Services under NAICS 561210 — related awards are listed below.

Contractor Information

UEI: HV8BH9BPG8Y9
Location: FREDERICK, MD
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related